Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck Cancer
Conditions
Interventions
- DRUG: XRP6976 (Docetaxel/Taxotere)
Sponsor
Sanofi